Home
Who we are
Pipeline
News
Contact
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric and orphan drugs.
Our mission is to develop essential medicines to improve
care and support of patients suffering from orphan diseases.
Latest news and reports
Latest news and report
2 February 2021
Opening of the operating pharmaceutical establishment
Read more
26 January 2021
Grant obtained from the region Île-de-France to support business activity development in Europe and the United States
Read more
19 January 2021
Signature of a licensing agreement for the development and marketing of Kigabeq® in China
Read more
12 October 2020
ORPHELIA Pharma to organize a Symposium at the SIOP congress 2020
Read more
5 October 2020
Inclusion of the first patient in a clinical study evaluating Kimozo
Read more
1 October 2020
Meet us at BIO-Europe 2020, October 26-29
Read more
14 September 2020
ORPHELIA Pharma will attend and support the annual SIOP Congress 2020
Read more
11 March 2020
ORPHELIA announces the appointment of Laurent Martin as Chief Pharmaceutical Affairs Officer
Read more
